disclaimer - 28 liberty · § shanghai henlius biotech co. ltd. is a joint venture company formed...

18
Disclaimer This presentation and the presentation materials distributed herewith include forward-looking statements. All statements, other than statements of historical facts, that address activities, events or developments that Fosun International Limited (the “Company”) expects or anticipates will or may occur in the future (including but not limited to projections, targets, estimates and business plans) are forward-looking statements. The Company’s actual results or developments may differ materially from those indicated by these forward-looking statements as a result of various factors and uncertainties, and other risks and factors beyond our control. In addition, the Company makes the forward-looking statements referred to herein as of today and undertakes no obligation to update these statements. The exchange rates used in this PPT are as of 2015/6/30 (USD/CNY=6.11 EUR/CNY=6.87 HKD/CNY=0.79 EUR/USD=1.12), unless otherwise stated 1

Upload: others

Post on 12-May-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Disclaimer

This presentation and the presentation materials distributed herewith include forward-looking statements.

All statements, other than statements of historical facts, that address activities, events or developments

that Fosun International Limited (the “Company”) expects or anticipates will or may occur in the future

(including but not limited to projections, targets, estimates and business plans) are forward-looking

statements. The Company’s actual results or developments may differ materially from those indicated by

these forward-looking statements as a result of various factors and uncertainties, and other risks and

factors beyond our control. In addition, the Company makes the forward-looking statements referred to

herein as of today and undertakes no obligation to update these statements. The exchange rates used in

this PPT are as of 2015/6/30 (USD/CNY=6.11 EUR/CNY=6.87 HKD/CNY=0.79 EUR/USD=1.12), unless

otherwise stated

1

Page 2: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

FosunGroupBusinessSegments

2

IntegratedFinance(Wealth) IndustrialOpera;ons

Insurance Investment WealthManagement InternetFinance

Health Happiness Steel PropertyDevelopment&Sales Resources

USDmn Profita>ributabletoownersoftheparent

IntegratedFinance(Wealth)

Insurance Investment WealthManagement Internetfinance2015 2014 2015 2014 2015 2014 2015 2014 323.72 171.85 450.85 337.74 90.75 47.09 16.28 -0.42

IndustrialOpera;ons Health Happiness Steel PropertyDevelopment&

Sales Resources

2015 2014 2015 2014 2015 2014 2015 2014 2015 2014 269.88 168.62 26.94 72.85 -143.03 43.08 460.54 368.85 -71.31 19.98

Ø  Asat31December2015,theGroup’stotalassetsamountedtoUSD62.4bln,up24.8%fromtheyearended2014Ø  Asat31December2015,netassetaSributabletoownersoftheparentreachedUSD11.6bln,up52.3%fromtheyearended2014Ø  ProfitaSributabletoownersoftheparentwasUSD1.2bln,up17.3%fromtheyearended2014

Page 3: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

7,660

2014 2015

47.7% 84.6%

2014 2015

20,954

2014 2015

25,003

3

AssetstoFocusonDemandsforWealth,HealthandHappinessfromMiddle-ClassFamilies

In2015,consumpUoncontributed66.4%ofChina’stotalGDPgrowth.Middle-classfamilieshavebecomethekeydrivingforcebehindthegrowthoftheconsumpUon.Health,happinessandfamilywealthmanagementarethemosthighlightedindustriesrelatedtothelifestyleofthemiddle-classfamilies.Fosunaimstomakepeoplewealthier,healthierandhappier.

TourismClubMedplanstoopen15resortsinChinainthenext3years;ThomasCookhasformedaChinesejointventurewithFosun;AcquiredHoshinoTomamuResort,oneofthemostrenownedresortsinJapan;FirstpermanentsiteforCirqueduSoleilinChinaistobebuiltinHangzhou.

MedicalCare13hospitals,2professionalnursingunitsand7privateclinicswith3,777bedsintotal

SeniorLivingCommunityAlreadylaunched:totalconstrucUonareaof96,700sq.m.with1,090bedsintotal;Developing:totalconstrucUonareaof342,259sq.m.with2,977bedsintotal.

WealthScaleofinves;bleinsuranceassetsisRMB160.4bn;ScaleoffundsunderdirectmanagementisRMB63.39bn;Scaleofthird-partyassetsthroughindirectmanagementisRMB56.8bn;Alotoflicensedresourcessupportdiversifieddevelopmentoffinancialbusiness

【】%

【】%

TotalAssets

Opera;ngRevenue

【】%

NetAssets

ProfitA>ributedtoOwnersoftheParent

RMBmn

2014 2015

74.8%

63.2%

47.7%

49.1%

45.1%

33.0%

77.2%

95.3%

205,416

44,308 303,385

38,672

5,185

PercentageofIntegratedFinance(Wealth),HealthandHappiness

%andcontribuUonamountoftheGroupin2014

%andcontribuUonamountoftheGroupin2015

Health

Tourism

Sports

game

Wealth

Managem

ent

Medicalinstruments

&diagnos;cs

Pharma

distrib

u;on

HealthNutri;on

Notes:H&AprojectissUllpendingforapproval.

33.9%75.7%

Page 4: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

4

ü  TakingcontrollingstakesininsurancecompaniesandfinancialinsUtuUonsandtohelpthemtoincreaseitscorecapital

ü  IniUalizefundsforcornerstoneinvestments

ü  Veryexclusivestrategicgreenfieldprojectsandfocuson“Unicorn”projects

FosunInterna;onal

(GroupPla^orm)

ü  IntegraUonofglobalindustrialecosystem

ü  MajoritystakeandM&A

ListedIndustrialSubsidiariesPla^orm

ü  Fixedincomeü  Equityinterestü  ProperUesü  Cash

InsuranceCompanyPla^orm

ü  InvesUnginlimitedshareholdings

ü  VC, PE, mutual fund, fund offund, dedicated fund, a porUonofmainlandrealestatefund

FundPla^orm

p  Focusondiscovering/inves;ngin“Unicorn”fornewinvestments1. VC/PEinvestments:guahao.com……2. Greenfieldinvestments:Mybank,Cainiao……3. SOEreform:Sinopharm……4. Publicmarketinvestment:FocusMedia……

p  Promoteinvestmentstotransforminto“Unicorns” FosunMedical,FosunTourism……p  TransformtheGroupintoa“Unicorn”inlong-termp  Increasecoopera;onwith“Unicorn”enterprises

Mul;-levelinvestmentpla^orminhelpwithcontrollingtheGroup’s

capitalexpenditures

Light-assetsstrategyoftheGroupplusthenaturalhighleveragein

insurance Develop“Unicorn”strategyvigoroursly

•  UUlizeidleandcheapresourcesthroughmatureproductsormodels

•  PromotetradiUonalindustriestobeintegratedwithmobileinternetandarUficialintelligence

FiveIndustriestoGiveBirthto“Unicorn”

TypicalModelstoGiveBirthto“Unicorn”

•  Totalinvestableassetsin6insurancecompanies/AccumulatedequityinvestmentsfortheGroupintheseinsurancecompanies=4.48;

•  NetgearingraUo(Netdebt/shareholders’equity)conUnuedtodecrease,from73.3%attheendof2014loweredto69.3%

“1+1+1”strategy

“1+1+1”strategyformedwith“wealth/health/happiness”+“property”+“insurance”toexertcoreproductpowerandhighearningoperaUngcapaciUesinwealth,healthandhappiness.Combiningwiththerapidturnoveronpropertytocreatelong-termstableincomeassetsandmatchwithlong-termliabiliUesininsurance

DevelopLight-assetStrategyand“Unicorn”StrategyVigorously

Health Happiness Wealth

Internet Innovative Production

Page 5: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

5

Con;nuedtoStrengthenProducts,IntegrateResourcesinEcosystemsandS;mulateOrganicGrowth

CruisesandPlanes TourismRetail

Productsandservicesderivingfrommaturebrands

Forexample:buildinguptourismecosystemInfaceofgrowthandupgradeoftourismconsumpUonoftheChinesemiddleclass, integratedexcellentresourcesgloballyandbuiltupthetourismecosystemthathastourismdes;na;onandcontentasitscore,tourismchannelasitsresourcelinkanddevelopmentcapabilityfortourismcomplexasitsbackbonetogeneratemul;-levelsynergies.

Domes;c&Overseas/Online&

OfflineTourismChannels

TourismDes;na;ons&Contents

Con;nuedtoPolishProductStrength

IntegratedResourcesinEcosystem

•  ClubMedlaunchedclubsforfamiliesandchildren;

•  Thomas Cook launched differenUatedand extensive overseas tourismproductsforChineseclients.

•  InsurancePortugalandLuzSaúde (GuangmingHospital) jointly launchedhealthcaremanagementservices;

•  FosunPharma:theGrouphasappliedforatotalof89pharmaceuUcalmanufacturingand R&D patents, obtained 15 licensed patents, among them: 9 invenUon patents(including 1U.S. patent); invested inU.S. dayUmeoperaUon center to explore newmedicalservicemodel;

•  Putgreatemphasisonfollowingfourmajorsectors:populaUonaging,newborns,sub-healthandtumors.

•  United Family Healthcare and ChanchengHospital joined hand with Yong’an P&CInsurance to launch special insuranceproducts;

•  Fosunling and CF Finance jointly launchedABSproducts.

Happiness Health Wealth

Page 6: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

GlobalInvestmentMap

6

Portugal

CirqueduSoleil,2015Canada

Fidelidade,2014

Osborne,2014Spain Caruso,2013

Italy

FolliFollie,2011 Greece

ROCOil,2014

SecretRecipe,2014Malaysia

IDERA,2014Japan

ClubMed,2013France

H&A (2),2015

IsraelAlmaLasers,2013

Germany

Australia

Studio8,2014

St.John,2013

Ironshore,2015

28Liberty,2013

MIG,2015

Ambrx,2015

U.S.

Notes:1.  ThemaponlyincludesinvestmentprojectsfromtheGroupanditsmanagedfunds2.  H&Aprojectispendingapprovalandisnotcompletedyet

SilverCross,2015

U.K.

LloydChamber,2013

Resolu;onProperty,2015

Page 7: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

New York

Los Angeles

San Francisco

Houston

Real-estate development and management Various investment teams

Film and entertainment investments Real estate investments

VC-Fosun Kinzon Capital Healthcare team

Energy investments

Fosun Investment Bases

Fosun has invested a total of USD 5 billion in North America §  4 investment bases were established and around 9,000 jobs have been maintained or created

Fosun Group FootprintsinNorth America

7

Page 8: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Fosun Group Milestones inNorthAmerica

8

IronshoreMeadowbrook

Insurance Investments

St.JohnKnitsStudio8CirqueduSoleil

Fashion & Lifestyle investments

28LibertyMadison

Real Estate Investments BeyondSpringPharmaSaladaxBiomedicalNature’sSunshineHandaPharmaHenliusBiopharmaFochonSovereignHealthSystemAmbrxAstuteMedicalRockwellMedical

Health and Medical Treatment Investments VC Investments

ScanaduChosenStyleSeatConnectGotItTapingo

2014.6

2013.12 2015.4 2013.3 2015.2

2014.12 2013.4

2015.1

2015.6 2014.7

2014.10 2014.10

2015.2 2012.12

2015.5 2015.10

2016.2

Page 9: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Fosun Group inNorthAmericaIntegratedFinance

9

•  In May 2015, Fosun announced a full acquisition of Ironshore for USD 1.84 billion. Fosun decided to increase its share holdings after its original purchase of 20% of the company in August 2014 and made Ironshore a fully-owned subsidiary. The company has established 23 offices in 7 countries, hiring more than 531 U.S. employees, of whom 200 were based in the New York area

•  Ironshore was established in 2006, and through its multiple subsidiary international platforms, Ironshore provides global clients with special P&C insurance; 2013 annual gross premium of USD 2.0 billion with 2009 - 2013 CAGR of 39.1%

§  Ironshore was rated by A.M. Best. one of the Top 10 American Specialty Insurance Companies in 2012; the company was ranked 11th in E&S market rankings in 2013

§  On December 31, 2014, Fosun acquired Meadowbrook (MIG) for approximately USD 433 million. With headquarters in Southfield Michigan, there are 25 offices across the United States and 929 employees, having fully licensed insurance business in 50 states

§  MIG is a non-life insurance company focusing on small- and medium-sized enterprises, and it primarily offers long tail liability insurance §  The company was founded in 1995 and went public on the New York Stock Exchange in 1995. As of September 30, 2014, the company had

total investments of USD 2.74 billion, new assets of USD 448 million, and an annual total insured amount of USD 742 million

Integrated Finance: Creating Insurance-Oriented Comprehensive Financial Capability.

Page 10: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Fosun Group inNorthAmericaHealthcare

10

§  In 2009, Fosun Pharma acquire Handa Pharmaceutical's convertible bonds by USD 5.42 million. It employs 7 staff members in the US §  Handa Pharmaceuticals is an American R&D company specializing in sustained and controlled release preparation technology and the

development of generic drugs. Its generic big brand sustained release quetiapine obtained FDA approval and was the first product by a Chinese pharmaceutical connected company to obtain approval as a primary filer

§  Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It has 9 employees in the US.

§  The company focuses on the development, production and commercialization of monoclonal antibody drugs with cutting-edge technology Current Products under development cover a variety of therapeutic sectors, including but not limited to oncology and autoimmune diseases

§  Fochon Pharma is established in 2009 by Fosun Pharma and a few other overseas Chinese scientists. It has 5 full time American employees

§  In May 2009, Fosun Pharm has registered Fochon Pharma in San Francisco, dedicated to small molecule drug research and development Aiming to be a worldwide innovative company in pharmaceutical development, Fochon has been developing proprietary, orally effective therapies for serious unmet medical needs in diabetes and cancer based on structure-based drug design technology. It has created a highly efficient, cost- and time-effective global operating structure for independently patented drugs

§  In December 2012, Fosun invested USD 1.6 million in BeyondSpring Pharmaceuticals. It has 10 full time employees §  BeyondSpring’s Plinabulin is a new form of immunotherapy drug with a global patent for the treatment of lung cancer. The approach has thus

far treated a total of 141 cancer patients in the United States and internationally, and exhibits marked effects and good safety in late stage lung cancer, brain cancer, colon cancer, and pancreatic cancer. The period of efficacy of the treatment is longer than any other drugs on the market

Page 11: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Fosun Group inNorthAmericaHealthcare

§  In March 2013, Fosun Pharmaceutical invested nearly USD 22.40 million in Saladax. It has nearly 50 staff members in the U.S §  Saladax licenses Fosun China Region exclusive distribution rights and product manufacturing rights. Saladax is expected to establish a unique

biochemical testing platform for the Chinese and even global markets that will be capable of carrying out testing for chemotherapy concentrations, thus enabling better analysis of the treatment effects of chemotherapy drugs

§  In May 2015, Shanghai Fosun Pharma announced an USD 45 million investment in Ambrx, the transaction was closed in Q2 2015. It has around 60 employees

§  Ambrx is a biotech company involved in clinical research stages and specializes in uncovering and developing new protein drugs. Its exclusive technical platform is able to precisely couple small molecules with pharmaceutical activity to specific locations on large protein molecules

§  In Oct 2015, Fosun Pharma invested $20 million in Astute as an agreement with Shanghai Fosun Long March Medicine Science Co for distribution of Astute's NephroCheck® Test on the Astute140® Meter in China. In addition to its planned launch of the NephroCheck® Test in China.

§  Founded in 2007, Astute Medical focuses on novel biomarkers to create clinically useful tools for assessing acute conditions in the critically ill patient. It is dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. Currently, Astute has around 68 employees.

§  On Feb 2016, Wanbang Biopharmaceutical Co., a subsidiary of Shanghai Fosun Pharmaceutical Co., Ltd, entered into an exclusive licensing agreement with Rockwell Medical, Inc. for Triferic and Calcitriol Injection in China market.

§  Rockwell Medical, a Wixom, MI based and Nasdaq-traded company, is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. It has 300 employees in the US.

Page 12: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Fosun Group inNorthAmericaHealthcare

12

§  On June 26, 2014, Fosun Pharma invested in Nature's Sunshine Products (Nasdaq:NATR) with $46.3 million. §  With the private placement transaction, Nature's Sunshine Products, Inc., a leading natural health and wellness company

engaged in the manufacture and direct selling of nutritional and personal care products, has also signed a definitive agreements with respect to the formation of a China joint venture to market and distribute Nature's Sunshine and Synergy products in China.

§  Based in Lehi, Utah, the company has 599 employees all across the US and total 975 employees globally..

§  On Jan 9, 2015, Fosun Pharma made an investment of USD 35 million in Amerigen Pharmaceuticals Limited to help deepen its product pipeline through additional investments in product development and business development.

§  Amerigen Pharmaceuticals is a group of companies engaged in all phases of the generic pharmaceutical business. Headquartered in Lyndhurst, New Jersey, the company has 17 employees in the US and has US FDA and CFDA approved operations in Suzhou, China.

§  In April 2015, Fosun Pharma invested USD 40 million in Sovereign Health Services,Inc. It has 820 employees in the US. §  Sovereign Health System is a fully integrated, multi-specialty community healthcare system serving residents of the New York

City metropolitan area. It has four radiation oncology centers, more than a dozen ambulatory surgery centers, three urgent care centers, and dozens of primary care and specialty physicians, with plans for strategic expansion. By providing managerial expertise and operational efficiencies to its care centers and medical practices, Sovereign Health System delivers high-quality, cost-effective healthcare valued by both patients and insurers.

Page 13: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Fosun Group in North America Happiness&FashionableLifestyle

13

§  In April 2015, Fosun invested USD 375 million in partnership with TPG to acquire Cirque du Soleil. Cirque du Soleil has over 4,000 employees globally, 1300 of them are artists

§  Cirque du Soleil was established in 1984 in Quebec, Canada, and is the world's largest circus producer. The company has received numerous leading international performance awards, including Emmy Awards and Bambi Awards, and is considered the jewel of Canada

§  In June 2015, Fosun announced a partnership with Hangzhou Industrial Investment Group Limited to introduce Cirque du Soleil's to the Chinese market

§  In October 2014, Fosun completed investments in Studio 8 for USD 200 million. There are 24 full-time American employees, and each movie production team will recruit more crew members

§  Studio 8 is a Hollywood film production company founded by former president of Warner Brothers Motion Pictures, Jeff Robinov §  In early 2015, Studio 8 announced an investment in world class director Ang Lee's new film "Billy Lynn's Long Halftime Walk"

§  In April 2013, Fosun completed a USD 55 million investment in America‘s high-end women's apparel brand St John Knits, making Fosun the second largest shareholder in St. John Knits

§  Including its employees at the flagship store on Fifth Avenue in New York, St. John Knits has 1,900 employees in North America in the United States, Canada, and Mexico

§  As an American high-end women's apparel brand, St. John Knits has a large base of loyal customers in commercial and political circles, including First Lady Michelle Obama and former Secretary of State Hillary Clinton

Page 14: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Fosun Group inNorth America Real Estate

14

§  The Madison Project, located in Midtown Manhattan (Madison Avenue, near Fifth Avenue and 30th), is a luxury apartment residential project in the NoMad neighborhood with a total building area of approximately 310,000 square feet. Fosun has two dedicated American employees overseeing the project

§  This project is a collaboration between Fosun and local developer JD Carlisle, featuring a total development cost of approximately USD 470 million. On January 15, 2015, Fosun signed an agreement with JD Carlisle

§  On October 18, 2013, Fosun purchased this A-class office tower located in Manhattan for a total amount of USD 725 million. There are currently 15 employees working on this project as part of Fosun's New York property team, 80% of employees are local Americans

§  28 Liberty has a total area of 2.2 million square feet, is 60 storeys high and has 5 levels underground, as well as a 2.5-acre plaza §  Previously known as One Chase Manhattan Plaza, it is a landmark building. On January 12, 2015, the building had its name changed to 28

Liberty

Real Estate: Striving to Develop Real Estate Projects that Match Insurance Requirements for Investment

Page 15: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Fosun Group inNorth America Venture Capital

15

•  In February 2015, Fosun Kinzon Capital and DCM led investments in Chosen, in which Fosun Kinzon Capital put in USD 1.6 million •  Chosen is a mobile platform enabling anyone to become an "American Idol": By using a mobile device to record and display one's

talent, users can rate and participate

•  In August 2014, Fosun Kinzon Capital invested USD 1.3 million in Gotit •  GotIt is a knowledge sharing platform based on mobile devices wherein anyone's questions can be asked via words or pictures and

answers and explanations can be received in real-time from worldwide experts

•  In October 2014, Fosun Kinzon Capital invested USD 6.8 million in Connect •  Connect was established in April 2012 and aimed to redefine mobile social media. Its early-stage products connected via API,

integrating various messages from social media apps and displaying and providing reminders about information from friends on a map

•  In June 2015, Fosun Kinzon Capital led investments in StyleSeat with funding of USD 20 million •  StyleSeat is headquartered in San Francisco, California and is an O2O cosmetics and hairstyling mobile platform. The platform currently

has over 300,000 independent cosmeticians and hairstyling experts and is still continuing to grow at a rapid pace

•  In March 2015, Fosun Kinzon Capital led investments in Tapingo with USD 6 million in conjunction with Qualcomm Ventures •  Tapingo is headquartered in San Francisco, California and provides meal ordering, meal delivery, as well as local e-commerce services while

at the same time covering and extending business into nearby commercial districts

•  In 2015, Fosun Kinzon Capital invested USD 5 million in Scanadu. Scanadu is a mobile medical technology start-up located in the Bay Area. The company's major product is the utilization of wearable devices to monitor the user‘s heart status (ECG, heart rate), body temperature, blood oxygen saturation, blood pressure, and other parameters, thereby allowing anyone to become their own family doctor

Page 16: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Fosun Group inNorth America Venture Capital

16

•  In 2016, Fosun Kinzon Capital led a $20 million round of Series-A financing in uSens Inc. •  Headquartered in San Jose, California, uSens Inc. creates 3D interactive solution for augmented and virtual reality. As a domain expert in 3D

graphics, Computer Vision, and Artificial Intelligence, uSens is one of the first companies to provide 3D free-hand tracking as well as inside-out 6DOF head position tracking for both mobile and tethered AR/VR systems. By replacing the need for any peripheral input device, uSens’ technology allows end users to immerse themselves in what uSens calls “Super Reality,” the most naturally interactive digital experience.

•  uSens currently has 20 employees in the US office.

•  In February 2015, Fosun Kinzon Capital invested $1 million in Earnest. •  Earnest is a technology company using data science, smarter design, and exceptional service to build the modern bank for the next generation.

•  GrubMarket is the leading e-commerce platform for organic food, bringing farmer’s market online and providing consumers and restaurants healthy and delicious produce. Grubmarket’s mission is to conveniently make fresh and healthy food accessible to everyone.

•  The company was founded in Feb, 2014, and was selected by Y-combinator 6 months later. Fosun Kinzon Capital led Grubmarket’s Series A investment, and other investors include GGV, Legend Capital, Battery Venture, AME Cloud, etc. The company is generating millions of dollar transaction on the platform and is growing rapidly.

Page 17: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

17

FosunGroupInterna;onalCorporateSocialResponsibility

To exhibit a spirit of giving back to the community in New York, Fosun strongly supports and sponsors the Manhattan Downtown region‘s cultural and community events, including the River To River Festival, the Downtown alliance food fair and etc

As a member the U.S.-China Chamber of Commerce, Fosun actively communicates with business leaders in both China and America, participating in talks, assisting in Sino-American business cooperations, and achieving goals of strategic dialog. Cooperating with the Yabuli Chinese Entrepreneurs Forum, beginning in 2010, a Sino-American entrepreneur forum and Fosun Night branding event have been held annually in New York

Fosun has partnered with Prudential Financial Inc. to organize young community volunteer awards and has introduced this award to China through its Fosun Foundation platform. Fosun co-hosted the award ceremony with Prudential every year

As a member of the United Nations Global Compact, Fosun works hard to practice sustainable development strategies in relation to corporate social responsibility, striving to create future leadership abilities and to work closely alongside global business schools and key opinion leaders among multinational companies

Focus on Community Contribution

Sino-US Business Connections

Focus on Young Volunteers Development

Global Business Leaders

Assisting Regions in Africa

As China's only WHO-certified manufacturer of antimalarial pharmaceuticals, Fosun Pharmaceutical provides the WHO with over 10 million doses of sodium artesunate annually. Fosun’s product as the world's only sodium artesunate injection, save the lives of thousands of children each day in Africa

Page 18: Disclaimer - 28 Liberty · § Shanghai Henlius Biotech Co. Ltd. is a joint venture company formed by Shanghai Fosun Pharma and Henlius Biopharmaceuticals Inc in December 2009. It

Thank You!

18